Autopsy report · NCT01400607

Neocartilage Implant to Treat Cartilage Lesions of the Knee

“Poor enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 9 years 2 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

ISTO Technologies, Inc.

Sponsor type

Industry

Conditions

Articular Cartilage Disorder; Degeneration; Articular Cartilage; Chronic Cartilage Injury; Acute Cartilage Injury; Defect of Articular Cartilage

Interventions

Neocartilage Implant/DeNovo® ET (Engineered Tissue Graft); Microfracture

Participants

14

Sites

9

Countries

United States

Trials that died the same way

• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (96% match in meaning)
• Embozene Microspheres for Uterine Fibroid Embolization (UFE)
  “Inadequate enrollment” (91% match in meaning)
• A Preliminary Study Utilizing a Flexible Endoscope for Pelvic Culdoscopy
  “Low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.